209 related articles for article (PubMed ID: 22710393)
1. Pleiotropic activity of lysophosphatidic acid in bone metastasis.
Peyruchaud O; Leblanc R; David M
Biochim Biophys Acta; 2013 Jan; 1831(1):99-104. PubMed ID: 22710393
[TBL] [Abstract][Full Text] [Related]
2. Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts.
David M; Wannecq E; Descotes F; Jansen S; Deux B; Ribeiro J; Serre CM; Grès S; Bendriss-Vermare N; Bollen M; Saez S; Aoki J; Saulnier-Blache JS; Clézardin P; Peyruchaud O
PLoS One; 2010 Mar; 5(3):e9741. PubMed ID: 20305819
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid: a potential mediator of osteoblast-osteoclast signaling in bone.
Sims SM; Panupinthu N; Lapierre DM; Pereverzev A; Dixon SJ
Biochim Biophys Acta; 2013 Jan; 1831(1):109-16. PubMed ID: 22892679
[TBL] [Abstract][Full Text] [Related]
4. New insights into the autotaxin/LPA axis in cancer development and metastasis.
Leblanc R; Peyruchaud O
Exp Cell Res; 2015 May; 333(2):183-189. PubMed ID: 25460336
[TBL] [Abstract][Full Text] [Related]
5. The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases.
Boucharaba A; Serre CM; Guglielmi J; Bordet JC; Clézardin P; Peyruchaud O
Proc Natl Acad Sci U S A; 2006 Jun; 103(25):9643-8. PubMed ID: 16769891
[TBL] [Abstract][Full Text] [Related]
6. Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.
Boucharaba A; Serre CM; Grès S; Saulnier-Blache JS; Bordet JC; Guglielmi J; Clézardin P; Peyruchaud O
J Clin Invest; 2004 Dec; 114(12):1714-25. PubMed ID: 15599396
[TBL] [Abstract][Full Text] [Related]
7. Secretion of IL-6 and IL-8 from lysophosphatidic acid-stimulated oral squamous cell carcinoma promotes osteoclastogenesis and bone resorption.
Hwang YS; Lee SK; Park KK; Chung WY
Oral Oncol; 2012 Jan; 48(1):40-8. PubMed ID: 21925926
[TBL] [Abstract][Full Text] [Related]
8. Platelets, autotaxin and lysophosphatidic acid signalling: win-win factors for cancer metastasis.
Leblanc R; Houssin A; Peyruchaud O
Br J Pharmacol; 2018 Aug; 175(15):3100-3110. PubMed ID: 29777586
[TBL] [Abstract][Full Text] [Related]
9. Biological roles of lysophosphatidic acid signaling through its production by autotaxin.
Okudaira S; Yukiura H; Aoki J
Biochimie; 2010 Jun; 92(6):698-706. PubMed ID: 20417246
[TBL] [Abstract][Full Text] [Related]
10. Osteolytic and osteoblastic bone metastases: two extremes of the same spectrum?
Ortiz A; Lin SH
Recent Results Cancer Res; 2012; 192():225-33. PubMed ID: 22307378
[TBL] [Abstract][Full Text] [Related]
11. Role of the autotaxin-lysophosphatidate axis in the development of resistance to cancer therapy.
Tang X; Benesch MGK; Brindley DN
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Aug; 1865(8):158716. PubMed ID: 32305571
[TBL] [Abstract][Full Text] [Related]
12. [Mechanisms of bone metastasis formation].
Peyruchaud O
J Soc Biol; 2007; 201(3):229-36. PubMed ID: 18157074
[TBL] [Abstract][Full Text] [Related]
13. Lysoglycerophospholipids in chronic inflammatory disorders: the PLA(2)/LPC and ATX/LPA axes.
Sevastou I; Kaffe E; Mouratis MA; Aidinis V
Biochim Biophys Acta; 2013 Jan; 1831(1):42-60. PubMed ID: 22867755
[TBL] [Abstract][Full Text] [Related]
14. Interaction of platelet-derived autotaxin with tumor integrin αVβ3 controls metastasis of breast cancer cells to bone.
Leblanc R; Lee SC; David M; Bordet JC; Norman DD; Patil R; Miller D; Sahay D; Ribeiro J; Clézardin P; Tigyi GJ; Peyruchaud O
Blood; 2014 Nov; 124(20):3141-50. PubMed ID: 25277122
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic acid, human osteoblast formation, maturation and the role of 1α,25-Dihydroxyvitamin D3 (calcitriol).
Mansell JP; Blackburn J
Biochim Biophys Acta; 2013 Jan; 1831(1):105-8. PubMed ID: 22561288
[TBL] [Abstract][Full Text] [Related]
16. Autotaxin and LPA receptor signaling in cancer.
Houben AJ; Moolenaar WH
Cancer Metastasis Rev; 2011 Dec; 30(3-4):557-65. PubMed ID: 22002750
[TBL] [Abstract][Full Text] [Related]
17. Bone defects in LPA receptor genetically modified mice.
Salles JP; Laurencin-Dalicieux S; Conte-Auriol F; Briand-Mésange F; Gennero I
Biochim Biophys Acta; 2013 Jan; 1831(1):93-8. PubMed ID: 22867754
[TBL] [Abstract][Full Text] [Related]
18. Exosome-associated lysophosphatidic acid signaling contributes to cancer pain.
Khasabova IA; Khasabov SG; Johns M; Juliette J; Zheng A; Morgan H; Flippen A; Allen K; Golovko MY; Golovko SA; Zhang W; Marti J; Cain D; Seybold VS; Simone DA
Pain; 2023 Dec; 164(12):2684-2695. PubMed ID: 37278638
[TBL] [Abstract][Full Text] [Related]
19. Autotaxin in embryonic development.
Moolenaar WH; Houben AJ; Lee SJ; van Meeteren LA
Biochim Biophys Acta; 2013 Jan; 1831(1):13-9. PubMed ID: 23022664
[TBL] [Abstract][Full Text] [Related]
20. [Function and biological activities of the autotaxin-LPA axis].
Li ZW; Zhao YR; Zhao C; Fu R; Li ZY
Sheng Li Xue Bao; 2011 Dec; 63(6):601-10. PubMed ID: 22193457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
